Revision in intimation dated 3rd September 2025 for allotment of 150000 and 500 equity shares under Management Employees Stock Option Plan 2018 ( MESOP 2018 ) and ESOP Plan 2008 ( ESOP 2008 ) respectively.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has revised its earlier intimation dated 3rd September 2025 regarding the allotment of equity shares to employees. The revision pertains to the allotment of 150,000 equity shares under the Management Employees Stock Option Plan 2018 (MESOP 2018) and 500 equity shares under the ESOP Plan 2008 (ESOP 2008). This is a routine corporate action involving the issuance of shares to employees as part of their stock-based compensation. The total number of shares being allotted across both plans is 150,500 equity shares.
This allotment will result in a minor dilution of existing shareholders' equity. It is a routine employee compensation event and is unlikely to have a material impact on the stock price.